Literature DB >> 27340999

Fibrous Dysplasia of the Temporal Bone with External Auditory Canal Stenosis and Secondary Cholesteatoma.

Yu-Hsi Liu1, Kuo-Ping Chang.   

Abstract

Fibrous dysplasia is a slowly progressive benign fibro-osseous disease, rarely occurring in temporal bones. In these cases, most bony lesions developed from the bony part of the external auditory canals, causing otalgia, hearing impairment, otorrhea, and ear hygiene blockade and probably leading to secondary cholesteatoma. We presented the medical history of a 24-year-old woman with temporal monostotic fibrous dysplasia with secondary cholesteatoma. The initial presentation was unilateral conductive hearing loss. A hard external canal tumor contributing to canal stenosis and a near-absent tympanic membrane were found. Canaloplasty and type I tympanoplasty were performed, but the symptoms recurred after 5 years. She received canal wall down tympanomastoidectomy with ossciculoplasty at the second time, and secondary cholesteatoma in the middle ear was diagnosed. Fifteen years later, left otorrhea recurred again and transcanal endoscopic surgery was performed for middle ear clearance. Currently, revision surgeries provide a stable auditory condition, but her monostotic temporal fibrous dysplasia is still in place.

Entities:  

Mesh:

Year:  2016        PMID: 27340999     DOI: 10.5152/iao.2016.1381

Source DB:  PubMed          Journal:  J Int Adv Otol        ISSN: 1308-7649            Impact factor:   1.017


  2 in total

1.  Fibrous dysplasia: rare manifestation in the temporal bone.

Authors:  Thaís de Carvalho Pontes-Madruga; Halana Valéria Carneiro Filgueiras; Daniel Marcus San da Silva; Leonardo Sales da Silva; José Ricardo Gurgel Testa
Journal:  Braz J Otorhinolaryngol       Date:  2020-07-21

Review 2.  Different clinical presentation and management of temporal bone fibrous dysplasia in children.

Authors:  Józef Mierzwiński; Justyna Kosowska; Justyna Tyra; Karolina Haber; Maria Drela; Dariusz Paczkowski; Paweł Burduk
Journal:  World J Surg Oncol       Date:  2018-01-15       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.